Febrile neutropenia remains an important complication of treatment with cytotoxic
chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this …

Most oncologic emergencies can be classified as metabolic, hematologic, structural, or
treatment related. Tumor lysis syndrome is a metabolic emergency that presents as severe …

Purpose To provide an updated joint ASCO/Infectious Diseases Society of American (IDSA)
guideline on outpatient management of fever and neutropenia in patients with cancer …

Background We aimed to describe the current rates of inappropriate empirical antibiotic
treatment (IEAT) in oncohematological patients with febrile neutropenia (FN) and its impact …

We analyzed risk factors for mortality in febrile neutropenic patients with bloodstream
infections (BSI) presenting with septic shock and assessed the impact of empirical antibiotic …

Bacterial pneumonias cause disproportionate morbidity and mortality in patients with cancer,
despite the current aggressive use of prophylactic antibiotics and environmental hygiene …

Background There is currently no consensus on optimal duration of antibiotic treatment in
febrile neutropenia. We report on the clinical impact of implementation of antibiotic de …

Objectives To evaluate the diagnostic performance and clinical impact of metagenomic next-
generation sequencing (mNGS) of plasma microbial cell-free DNA (mcfDNA) in febrile …

Background Antibiotic delivery to patients with fever and neutropenia (F&N) in< 60 min is an
increasingly important quality measure for oncology centers, but several published reports …

The aim of this survey was to summarize the current antimicrobial practice in febrile
neutropenia and the presence of key aspects of antimicrobial stewardship. A questionnaire …